title: Clinical Improvement with JAK2 Inhibition in Chuvash Polycythemia.
authors: Washington University School of Medicine, St. Louis, MO.
authors: Amy W
authors: AW
authors: Zhou
authors: Washington University School of Medicine, St. Louis, MO.
authors: Eric M
authors: EM
authors: Knoche
authors: Washington University School of Medicine, St. Louis, MO.
authors: Elizabeth K
authors: EK
authors: Engle
authors: University of Rochester Medical Center, Rochester, NY.
authors: Makiko
authors: M
authors: Ban-Hoefen
authors: Washington University School of Medicine, St. Louis, MO stoh@dom.wustl.edu.
authors: Charu
authors: C
authors: Kaiwar
authors: Washington University School of Medicine, St. Louis, MO stoh@dom.wustl.edu.
authors: Stephen T
authors: ST
authors: Oh
mesh_terms: D000328:Adult; D002675:Child, Preschool; D006801:Humans; D007223:Infant; D053614:Janus Kinase 2 / Q000037:antagonists & inhibitors*; D008297:Male; D009570:Nitriles; D011086:Polycythemia / Q000151:congenital* / Q000188:drug therapy; D011720:Pyrazoles / Q000627:therapeutic use*; D011743:Pyrimidines
chemical_list: D009570:Nitriles; D011720:Pyrazoles; D011743:Pyrimidines; C540383:ruxolitinib; C507924:JAK2 protein, human; D053614:Janus Kinase 2